All TreatGx users now have access to the updated treatment algorithms for Acute Gout and Peripheral Artery Disease. As always, both of these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. Acute Gout This update accounted for revisions made to existing clinical guidelines...
All TreatGx users now have access to the updated treatment algorithms for Depression, Heart Failure - Fluid Retention, Chronic Pain - Trigeminal Neuralgia, and Hyperlipidemia. Depression In light of its recent approval in Canada and the US, esketamine nasal spray (Spravato) has been added to the Depression Augmentation/Adjunctive therapy options. Highlights include: Approved by Health Canada for adjunctive use with an SSRI or...
All TreatGx users now have access to the updated treatment algorithms for Atrial Fibrillation – Anticoagulation and Anxiety – Social Anxiety Disorder. Atrial Fibrillation – Anticoagulation The updated atrial fibrillation anticoagulation algorithm provides a streamlined approach to medication options when initiating or switching between anticoagulants. Switching instructions have been updated...
TreatGx has undergone some exciting changes to make it easier and faster than ever to generate personalized medication treatment options. As a result of this update, you may notice that some question categories may display as red and require you to re-input information. We’ve updated the...
All TreatGx users now have access to the updated treatment algorithms for Gastroesophageal Reflux Disease (GERD) and H. pylori Eradication. The GERD algorithm provides pharmacotherapy options for adults with mild/intermittent or moderate-severe GERD symptoms, and treatment options for pregnancy. The H. pylori Eradication algorithm provides pharmacotherapy options for adults...
All TreatGx users now have access to the updated treatment algorithm for Atrial Fibrillation – Rate Control. The updated Rate Control algorithm provides personalized medication treatment options for each patient based on whether they have certain cardiovascular comorbidities , including those with heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, or hypertension. This algorithm continues to provide...
All TreatGx users now have access to the updated algorithms for Chronic Gout and Prevention of Non-Steroidal Anti-Inflammatory (NSAID)-Induced Gastrotoxicity. Chronic Gout: This comprehensive update incorporates information from the most recent clinical guidelines and literature, including updates from the American College of Rheumatology [1], BMJ Best Practice [2], and the European League Against Rheumatism [3]. New information about pharmacogenetic testing for select populations before starting...
All TreatGx users now have access to the updated Generalized Anxiety Disorder treatment algorithm. This comprehensive update incorporates information from the most recent clinical guidelines and literature from the American Family Physician[1], the BMJ[2], Lancet[3], and others. Highlights of the update include: 8 new medication treatment options that have been added based on the latest evidence...
TreatGx users now have access to the updated Chronic Pain – Low Back Pain treatment algorithm. A key feature of this update is being able to view all medication options at-a-glance. In addition to displaying personalized dosing options based on kidney function, liver function, drug-drug interactions, medical history, and pharmacogenetics (whether available or not), and continuing to provide guidance on gastroprotection in patients at high...
All TreatGx users now have access to the updated Chronic Pain - Neuropathic Pain treatment algorithm. Finding the optimal therapy to meet goals for chronic pain management can be challenging. This major update not only brings together information from multiple sources but enables it to...
